These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17105835)

  • 81. Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong.
    Ho PL; Chuang SK; Choi YF; Lee RA; Lit AC; Ng TK; Que TL; Shek KC; Tong HK; Tse CW; Tung WK; Yung RW;
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):245-50. PubMed ID: 18272316
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Which rate describes the MRSA situation appropriately?].
    Gastmeier P; Chaberny IF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1480-2. PubMed ID: 17583833
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues].
    Gauzit R
    Presse Med; 2003 Apr; 32(13 Pt 2):S17-20. PubMed ID: 12754445
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobial.
    Nathwani D
    J Hosp Infect; 2001 Dec; 49 Suppl A():S33-41. PubMed ID: 11926439
    [TBL] [Abstract][Full Text] [Related]  

  • 85. tedizolid (SIVEXTRO*) in skin and soft-tissue infections.
    Prescrire Int; 2017 Mar; 26(180):63-64. PubMed ID: 30730618
    [No Abstract]   [Full Text] [Related]  

  • 86. Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial.
    Biedenbach DJ; Jones RN
    Clin Microbiol Infect; 2003 Oct; 9(10):1035-7. PubMed ID: 14616748
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia.
    Castagnola E; Moroni C; Gandullia P; Oddone M; Peri C; Casciaro R; De Alessandri A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1120-1. PubMed ID: 16495284
    [No Abstract]   [Full Text] [Related]  

  • 88. Cost avoidance using linezolid for methicillin-resistant Staphylococcus aureus infections in a specialist diabetes foot clinic.
    Young MJ; Hodges G; McCardle JE
    J Antimicrob Chemother; 2012 Dec; 67(12):2974-5. PubMed ID: 22904240
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Utility of linezolid in cystic fibrosis].
    Girón-Moreno RM; Ruiz-Velasco LM; Buendía V
    Enferm Infecc Microbiol Clin; 2004; 22(6):369-70. PubMed ID: 15228910
    [No Abstract]   [Full Text] [Related]  

  • 90. Out-of-pocket costs and prescription reversals with oral linezolid.
    Pasquale MK; Louder AM; Deminski MC; Chambers RB; Haider S
    Am J Manag Care; 2013 Sep; 19(9):734-40. PubMed ID: 24304256
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment with linezolid and rifampicin for 18 months for recurrent infection of a megaprosthesis in a patient with Ewing's sarcoma.
    Prugger V; Egner S; Windhager R; Mitteregger M; Bertha G; Wenisch C
    Int J Antimicrob Agents; 2004 Dec; 24(6):628-30. PubMed ID: 15555895
    [No Abstract]   [Full Text] [Related]  

  • 92. Antibiotic available for compassionate use.
    AIDS Patient Care STDS; 1998 Feb; 12(2):150. PubMed ID: 11361920
    [No Abstract]   [Full Text] [Related]  

  • 93. [Modern potential of antimicrobial therapy in the treatment of wounded soft tissue infections and osteomyelitis].
    Blatun LA
    Antibiot Khimioter; 2002; 47(9):31-6. PubMed ID: 12619519
    [No Abstract]   [Full Text] [Related]  

  • 94. A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.
    Wilson SE; Solomkin JS; Le V; Cammarata SK; Bruss JB
    Am J Surg; 2003 Apr; 185(4):369-75. PubMed ID: 12657392
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comment on: A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections.
    Rodgers MP; Wertheim HFL
    J Antimicrob Chemother; 2022 Oct; 77(11):3209-3210. PubMed ID: 35791752
    [No Abstract]   [Full Text] [Related]  

  • 96. Linezolid: safety and efficacy monitoring.
    Bolhuis MS; Pranger AD; Alffenaar JW
    Eur Respir J; 2012 May; 39(5):1275-6; author reply 1276-7. PubMed ID: 22547740
    [No Abstract]   [Full Text] [Related]  

  • 97. Soft-tissue infection and underlying calcinosis of CREST syndrome.
    Tangri N; Young BM
    CMAJ; 2006 Oct; 175(9):1059. PubMed ID: 17060652
    [No Abstract]   [Full Text] [Related]  

  • 98. Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study.
    Santos T; Carvalho R; Abreu MA; Reis E; Couto de Carvalho A
    Acta Med Port; 2020 Feb; 33(2):150. PubMed ID: 32035503
    [No Abstract]   [Full Text] [Related]  

  • 99. Clinical trial of sulphonamide Ro-4-4393 in staphylococcal infections.
    Choudhury DS; Banerjee AK
    Bull Calcutta Sch Trop Med; 1966 Jul; 14(3):96. PubMed ID: 5981467
    [No Abstract]   [Full Text] [Related]  

  • 100. Bibliography. Current world literature. Skin and soft tissue infections.
    Curr Opin Infect Dis; 2006 Apr; 19(2):194-203. PubMed ID: 16514346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.